- by sedlv
- May 5 2024
Forbion Portfolio Company Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer
(May 2, 2024) | By Laura Asbjornsen, Portfolio News.
Exciting news today for Forbion portfolio company Mariana Oncology. The company announces a landmark acquisition deal with Novartis worth $1 billion in cash upfront and up to $750 million in potential milestone payments. This strategic alliance merges Mariana Oncology’s groundbreaking radiopharmaceutical pipeline and platform with Novartis’ renowned clinical development and commercialization prowess. The synergy promises a new era of innovation and progress in the fight against cancer.
Read more about Novartis’ announcement and the acquisition details here: https://lnkd.in/g7CmCfbx
This milestone follows a remarkable journey, including an oversubscribed $175 million Series B financing round in September 2023. Congratulations to everyone involved! Vanessa Carle Gilles van Tienderen, PhD Geert-Jan Mulder #MarianaOncology #